JPH08501453A - 外来遺伝子を送達し、発現させるベクター - Google Patents

外来遺伝子を送達し、発現させるベクター

Info

Publication number
JPH08501453A
JPH08501453A JP6508518A JP50851894A JPH08501453A JP H08501453 A JPH08501453 A JP H08501453A JP 6508518 A JP6508518 A JP 6508518A JP 50851894 A JP50851894 A JP 50851894A JP H08501453 A JPH08501453 A JP H08501453A
Authority
JP
Japan
Prior art keywords
virus
vector
sense rna
gene
foreign gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6508518A
Other languages
English (en)
Japanese (ja)
Inventor
ウォーカー，ピーター・ジョン
プレハウド，クリストフ・ジーン
カウリー，ジェフ・アレクサンダー
Original Assignee
コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション filed Critical コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション
Publication of JPH08501453A publication Critical patent/JPH08501453A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20123—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP6508518A 1992-09-28 1993-09-28 外来遺伝子を送達し、発現させるベクター Pending JPH08501453A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPL497492 1992-09-28
AU4974 1992-09-28
PCT/AU1993/000495 WO1994008022A1 (fr) 1992-09-28 1993-09-28 Vecteur transportant et exprimant un gene etranger

Publications (1)

Publication Number Publication Date
JPH08501453A true JPH08501453A (ja) 1996-02-20

Family

ID=3776443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6508518A Pending JPH08501453A (ja) 1992-09-28 1993-09-28 外来遺伝子を送達し、発現させるベクター

Country Status (5)

Country Link
EP (1) EP0672153A4 (fr)
JP (1) JPH08501453A (fr)
IL (1) IL107139A0 (fr)
WO (1) WO1994008022A1 (fr)
ZA (1) ZA937164B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2210273T5 (es) * 1994-07-18 2010-03-29 Conzelmann, Karl-Klaus, Prof. Dr. Virus con arn de cadena negativa no segmentado recombinante infeccioso.
DE19503082A1 (de) * 1995-02-01 1996-08-08 Univ Ludwigs Albert Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
JPH11512609A (ja) 1995-09-27 1999-11-02 アメリカ合衆国 クローン化されたヌクレオチド配列からの感染性ＲＳウイルス（ｒｅｓｐｉｒａｔｏｒｙ ｓｙｎｃｙｔｉａｌ ｖｉｒｕｓ）の生産
KR100754091B1 (ko) * 1995-10-31 2007-08-31 가부시끼가이샤 디나벡 겡뀨쇼 자율 복제 능력을 갖는 (-)쇄 ｒｎａ 바이러스 벡터
EP0863202B1 (fr) 1995-11-01 2010-06-09 Dnavec Research Inc. Virus sendai recombinant
CA2253595A1 (fr) * 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services Production de transfectants viraux au moyen de proteines nucleocapsidiales derivees d'adn de recombinaison
US6818209B1 (en) 1998-05-22 2004-11-16 Oxford Biomedica (Uk) Limited Retroviral delivery system
AU7350798A (en) * 1997-04-29 1998-11-24 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
KR20010074493A (ko) * 1998-05-22 2001-08-04 찰스 굿맨 레트로바이러스 전달 시스템
WO2002098457A2 (fr) * 2001-01-17 2002-12-12 Thomas Jefferson University Rhabdovirus recombinants en tant que vaccins antiviraux actifs pour des virus de l'immunodeficience
GB0119852D0 (en) 2001-08-15 2001-10-10 Univ York Baculovirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
CA2113572A1 (fr) * 1991-07-17 1993-02-04 Peter J. Walker Vaccin ameliore
AU2366592A (en) * 1991-07-17 1993-02-23 Commonwealth Scientific And Industrial Research Organisation Improved vaccine

Also Published As

Publication number Publication date
ZA937164B (en) 1994-05-23
EP0672153A1 (fr) 1995-09-20
WO1994008022A1 (fr) 1994-04-14
IL107139A0 (fr) 1993-12-28
EP0672153A4 (fr) 1997-05-07

Similar Documents

Publication Publication Date Title
JP2773833B2 (ja) 感染性薬剤の供給系
EP0871482B1 (fr) Vesiculovirus de recombinaison et leurs utilisations
US5736388A (en) Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
JP2000505299A (ja) 合成ｈｉｖ遺伝子
ES2288769T3 (es) Composiciones de nodavirus recombinante y procedimientos.
KR20230134155A (ko) 재조합 변형된 백시니아 바이러스 앙카라 (mva) 필로바이러스 백신
HU230364B1 (hu) Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására
JPH06508037A (ja) 免疫不全ウイルス組換えポックスウイルスワクチン
KR20220016137A (ko) 변형된 아데노바이러스
KR20220041844A (ko) Hiv 항원 및 mhc 복합체
JPH08501453A (ja) 外来遺伝子を送達し、発現させるベクター
KR20230014694A (ko) 항원-코딩 카세트
KR20230046313A (ko) 다중에피토프 백신 카세트
KR20230006825A (ko) 전염성 질병 항원 및 백신
CN115666722A (zh) 包封的rna复制子和使用方法
JPH08504098A (ja) 抗体−エンベロープ融合蛋白を含有するレトロウィルスベクターを用いた細胞種特異的な遺伝子転移
JPH04500312A (ja) 自己アセンブルド欠損非自己増殖性ウイルス粒子
Lundstrom et al. Semliki Forest virus vectors for in vitro and in vivo applications
WO1998028004A1 (fr) Particule de l'hepatite delta contenant un immunogene de proteine de fusion
CN114269939A (zh) 汉坦病毒抗原组合物
EP0541753B1 (fr) NOUVEAU VARIANT gp160 NON-CLIVABLE, SOLUBLE, DE FORME HYBRIDE
US20150359877A1 (en) Viral Vaccine Vectors
KR20050046754A (ko) 단백질 중공 나노 입자 및 이를 이용한 약제
KR100686356B1 (ko) 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제
JP2011135897A (ja) 遺伝子送達のための改変ノダウイルスｒｎａ